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Abstract (145-words) 31 
 32 
During wound repair, branching morphogenesis and carcinoma dissemination, cellular 33 
rearrangements are fostered by a solid-to-liquid transition, known as unjamming. The biomolecular 34 
machinery behind unjamming and its pathophysiological relevance remain, however, unclear. Here, 35 
we study unjamming in a variety of normal and tumorigenic epithelial 2D and 3D collectives. 36 
Biologically, the increased level of the small GTPase RAB5A sparks unjamming by promoting non-37 
clathrin-dependent internalization of epidermal growth factor receptor that leads to hyper-activation 38 
of the kinase ERK1/2 and phosphorylation of the actin nucleator WAVE2. This cascade triggers 39 
collective motility effects with striking biophysical consequences. Specifically, unjamming in tumor 40 
spheroids is accompanied by persistent and coordinated rotations that progressively remodel the 41 
extracellular matrix, while simultaneously fluidizing cells at the periphery. This concurrent action 42 
results in collective invasion, supporting the concept that the endo-ERK1/2 pathway is a 43 
physicochemical switch to initiate collective invasion and dissemination of otherwise jammed 44 
carcinoma. 45 
 46 
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Collective motility is ruled by both biochemical and physical interactions that cells establish 48 
among each other and with their environment1, 2. During tissue growth cells are free to move, as in a 49 
fluid, but their motion becomes constrained as density increases. At a critical density - depending on 50 
a variety of biophysical parameters, such as intercellular adhesion, cortical tension, single cell 51 
motility, and cell shape variance, motility ceases and collectives rigidify undergoing jamming 52 
transition3-7. This transition ensures proper development of barrier properties in epithelial tissues, but 53 
also to act as a tumour suppressive mechanism3, 8. The reverse solid-to-liquid (unjamming) transition 54 
might, instead, represent a complementary gateway to epithelial cell migration, enabling mature 55 
tissues to flow3, 8, 9. However, how cells control the jamming/unjamming transition is unclear. 56 
Consistently with the emerging role of membrane trafficking in regulating cell migration plasticity 57 
and the mechanics of cell-cell interactions10, 11, we recently found that RAB5A, a master regulator of 58 
early endosomes necessary to promote a mesenchymal program of individual cancer invasion12, 13, 59 
impacts on the mechanics and dynamics of multicellular, normal and tumorigenic cell assemblies14. 60 
RAB5A overexpression re-awakens the motility of otherwise kinetically-arrested epithelial 61 
monolayers, promoting millimetre-scale, multicellular, ballistic cell locomotion and a flocking-fluid 62 
motility pattern through large-scale coordinated migration and local cell rearrangements14-16. 63 
Concurrently, monolayer stiffness, cell-cell surface contact and junctional tension increase, as well 64 
as the turnover of junctional E-cadherin and the extension of RAC1-driven protrusions14. 65 
Molecularly, impairing endocytosis, macropinocytosis or increasing fluid efflux abrogated RAB5A-66 
induced collective motility, suggesting that perturbations of trafficking processes are necessary for 67 
the unjamming transition. However, the molecular nature of these endocytic-sensitive pathways is 68 
yet unidentified. Even less clear is whether this transition occurs in relevant physiological, three-69 
dimensional settings and whether it can promote collective dissemination of dense, jammed 70 
carcinoma. 71 
Here, we identify a necessary axis of the flocking transition in a variety of jammed collectives.  72 
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RAB5A overexpression enhances the internalization of the epidermal growth factor receptor (EGFR) 73 
through non-clathrin-dependent routes into endosomes, which causes hyper-activation of the 74 
extracellular signal-regulated protein kinases ERK1/2 and the phosphorylation of the branched actin 75 
nucleator, WAVE217. This endocytic-ERK1/2 axis is sufficient to overcome the kinetic and 76 
proliferation arrest of mammary cysts in 3D. It also stimulates coherent rotation of breast ductal 77 
carcinoma in situ (DCIS) spheroid models, which causes both a radial gradient of cell fluidification 78 
and a stress-induced remodelling of the surrounding extracellular matrix. These effects combine to 79 
promote collective invasion of DCIS spheroids and ex vivo slices of orthotopically-implanted DCIS, 80 
pointing at the identified RAB5A-mediated, epidermal growth factor (EGF)-dependent activation of 81 
endosomal ERK1/2 as a key molecular route to the unjamming-via-flocking transition. 82 
Pathologically, the identified pathway appears relevant for breast carcinoma, RAB5A expression 83 
being upregulated in invasive foci of human DCIS and correlating with worse disease-free survival.   84 
 5 
Results 85 
 86 
EGFR trafficking controls flocking-liquid motility 87 
RAB5A expression promotes a flocking transition in jammed/solid epithelial monolayers14 through 88 
ill-defined molecular mechanisms and signalling axes. Particle Image Velocimetry (PIV) revealed 89 
that RAB5A expression enhanced cell motility, quantified by the root mean square velocity vRMS (see 90 
Methods). It further promoted millimetres-scale coordination, measured by the velocity correlation 91 
length Lcorr, and directed collective motion over a distance larger than ~700 µm, quantified by the 92 
persistence length Lpers, confirming previous results14. Removal of EGF, required for proliferation 93 
and single cell motility of MCF10A18, or addition of AG1478, an inhibitor of the EGFR kinase19, 94 
abrogated RAB5A-induced flocking (Supplementary Supplementary Movies 1, 2 and 4), with 𝑣RMS, 95 
Lcorr, and Lpers reverting to values typical of control cells (Figure 1A). These treatments further 96 
impacted on the uniformity of the migration pattern (Figure 1B). We confirmed these results using 97 
EGFP-H2B-expressing cells to visualize nuclear cell displacements (Supplementary Movie 3). 98 
Finally, similar EGF-dependency of collective motion was also observed in serum-starved, jammed 99 
keratinocyte monolayers, HaCat20, and in oncogenically-transformed MCF10A variants, 100 
MCF10.DCIS.com (Supplementary Figure 8A and - Supplementary Movie 20). 101 
Next, we tested whether alterations of endosomal biogenesis caused by RAB5A21 perturb EGFR 102 
cellular distribution, trafficking or signalling. Firstly, we showed that the total protein, but not the 103 
mRNA levels of EGFR were significantly reduced following induction of RAB5A expression (Figure 104 
1C-D). The fraction of phosphorylated EGFR was, instead, unexpectedly increased (Figure 1C). 105 
Secondly, RAB5A-expressing cells display a marked reduction of cell surface EGFR accompanied 106 
by increased intracellular EGFR, which accumulates in EEA1-positive, early endosomes (Figure 1E-107 
G). Measurements of the absolute number of surface EGFR using 125I-EGF binding corroborated the 108 
immunofluorescence (IF) data (Figure 1H). Finally, by IF analysis (Supplementary Figure 1A-C, 109 
Supplementary Table 1) and by determining the number of EGFR molecules on the plasma membrane 110 
 6 
(PM) (Supplementary Figure 1D), we verified that the removal of the ligand and inhibition of EGFR 111 
kinase activity restore EGFR surface and intracellular distribution to levels of control cells. 112 
 Intracellular accumulation of EGFR might originate from increased internalization or reduced 113 
recycling. In the former case, In the former case, it is known that for a low EGF dose (1 ng/ml), 114 
EGFRs are primarily internalized by Clathrin-mediated endocytosis22 and recycled back to the PM23. 115 
For large physiological EGF concentrations (20-to-100 ng/ml), non-Clathrin endocytosis24 is 116 
activated in parallel to Clathrin-mediated endocytosis23, 25. RAB5A expression significantly increased 117 
the apparent endocytic rate constant (Ke) at high (30 ng/ml), but not at low (1 ng/ml) 125I-EGF 118 
concentrations (Figure 2A). We also measured recycling rates of EGFR, which were not significantly 119 
altered by elevation of RAB5A (Figure 2B), and the total levels of EGFR, which were slowly, but 120 
progressively decreased over time consistent with the augmented non-clathrin internalization that 121 
target EGFR to degradation (Supplementary Figure 1E). To reinforce this finding, we measured 122 
EGFR internalization at high doses of ligands after silencing critical determinants of Clathrin- and 123 
non-Clathrin-endocytosis. We found that silencing Dynamin-2 robustly reduced EGFR 124 
internalization by more than 80% in both control and RAB5A cells, consistent with the expected 125 
requirement of this protein for EGFR entry (Figure 2C-D, Supplementary Table 2). The silencing of 126 
Clathrin inhibited EGFR internalization to an extent similar to the one achieved by Dynamin-2 siRNA 127 
in control cells, but was significantly less effective in RAB5A-expressing cells (Figure 2C-D, 128 
Supplementary Table 2). Finally, the RAB5A-dependent increased rate of endocytosis was reduced 129 
to control levels after silencing of the ER resident protein Reticulon 3 (RTN3), essential for non-130 
Clathrin endocytosis25 (Figure 2C), or by impairing macropinocytosis using 5-(N-ethyl-Nisopropyl) 131 
amiloride, EIPA26 (Figure 2E). Collectively, these findings indicate that RAB5A promotes EGFR 132 
non-Clathrin endocytosis, leading to accumulation of EGFR into early endosomes and, possibly, to 133 
the re-awakening of collective motion. Indeed, silencing of Dynamin-2 (Supplementary Figure 2A-134 
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B, Supplementary Movie 5), or RTN3, but not of its highly-related ER resident protein RTN4 135 
(Supplementary Figure 2C-D, Supplementary Movie 6), impaired RAB5A-induced flocking. 136 
 137 
RAB5A activates ERK1/2 to regulate cell protrusions dynamics 138 
EGFR signalling has been proposed to be initiated at the plasma membrane but to continue in 139 
endosomes27-29, which act as signalling quanta-like platforms where phosphorylated EGFR can be 140 
packaged at constant mean amounts30. As a consequence, altering the size and number of endosomes 141 
directly affected EGFR signalling. Hence, we monitored EGFR downstream pathways following 142 
RAB5A expression.  143 
  We found no impact on phosphorylation levels of the two kinases AKT and p38, variably 144 
involved in motility, whereas phosphorylated ERK1/2 was increased (Figure 3A) and long-lived in 145 
RAB5A-expressing cells (Supplementary Figure 3A, Supplementary Table 3). We corroborated this 146 
finding by IF after mixing control and EGFP-H2B-RAB5A-expressing cells (Supplementary Figure 147 
3B). Notably, ERK1/2 activation was detectable only in RAB5A, but not in RAB5B- or RAB5C-148 
expressing cells (Supplementary Figure 3C-D). Only RAB5A increased significantly both the number 149 
and size distribution of EEA1-positive endosomes (Supplementary Figure 3E-H, Supplementary 150 
Table 4), and significantly reduced surface EGFR levels, while augmenting the number of EGFR+ 151 
structures (Supplementary Figure 4A-E). RAB5B, instead, had marginal effects on endosome size 152 
and number, whereas RAB5C decreased significantly endosome number but robustly increased the 153 
size of EEA1- and EGFR-positive endosomes, which were concentrated perinuclearly 154 
(Supplementary Figures 3E-H and 4A-E). RAB5B and RAB5C were also very inefficient in 155 
reawakening collective motion in jammed monolayers (Supplementary Figure 4F, Supplementary 156 
Movie 7). Additionally, pharmacological inhibition of ERK1/2 using PD0325901 that targets the 157 
upstream MEK kinase31, or SCH772984 that directly inhibits ERK1/2 activity, abrogated RAB5A-158 
induced flocking (Figure 3B, Supplementary Movie 8). Treatment with AG1478 or Dynasore, a small 159 
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molecule impairing Dynamin-2 activity32, inhibited RAB5A-mediated elevation of ERK1/2 (Figure 160 
3C) and blocked the reawakening of collective motion (Figure 1, Supplementary Movies 2, 9 and 161 
ref14), suggesting that RAB5A elevation might enhance endosomal ERK1/2 signalling. This 162 
conjecture was tested by generating a FRET EKAREV-ERK1/2 sensor33, targeted to the endosomes 163 
by appending the FYVE domain of SARA protein to its C-terminus34 (Supplementary Figure 4G-H). 164 
Removal of EGF or treatment with  165 
PD0325901 significantly impaired FRET efficiency validating the biological relevance of the sensor 166 
(Supplementary Figure 4I). More importantly, RAB5A-expressing cells displayed increased 167 
endosomal ERK1/2 FRET efficiency as compared to control monolayers (Supplementary Figure 4J). 168 
We further showed that global elevation of ERK1/2 phosphorylation induced by the expression of a 169 
constitutively activated MEK-DD did not reawaken motility in jammed monolayers (Supplementary 170 
Figure 5A-B, Supplementary Movie 10). Notably, MEK-DD had no impact of junctional straightness 171 
or morphology (Supplementary Figure 5C-D). Collectively, our findings indicate that ERK1/2 172 
activation is necessary, albeit not sufficient, to promote unjamming.  173 
 RAB5A-expressing, unjammed monolayers move in a directed fashion by extending oriented 174 
cryptic lamellipodia (Figure 3D and Ref14, 35). Cryptic lamellipodia depend on RAC1, which activates 175 
branched actin polymerization of the pentameric WAVE2 complex36. The key component of this 176 
complex, WAVE2 is phosphorylated by ERK1/2 on multiple serine residues, among which S343 and 177 
S351, to be activated and to control protrusion dynamics37. Consistently, we found that RAB5A 178 
expression increased the phosphorylation of WAVE2, but marginally of ABI1, another key 179 
component of the WAVE complex36, in an ERK1/2, EGFR and Dynamin-2-dependent manner 180 
(Supplementary Figure 6A-C). Additionally, by monitoring the dynamics of cells mosaically-181 
expressing EGFP-LifeAct, we found that pharmacological inhibition of ERK1/2 impaired the 182 
formation and dynamics of cryptic lamellipodia (Figure 3D-E, Supplementary Movie 11). Similar 183 
results were obtained by silencing of NAP1, a critical member of the complex. This treatment 184 
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destabilized both WAVE2 and ABI1 proteins (Figure 3F), as previously shown38, 39, impaired cryptic 185 
lamellipodia dynamics (Figure 3G, Supplementary Movie 12), flocking	(Figure 3H, Supplementary 186 
Movie 13), and wound closure (Supplementary Figure 6D-F, Supplementary Movie 14). Silencing of 187 
the sole WAVE2 in MCF10A cells, which express also WAVE1 and WAVE3 mRNA 188 
(Supplementary Figure 6G), was, as expected, less effective (Supplementary Figure 6D-E, 189 
Supplementary Movie 14). 190 
 191 
Unjamming terminally-differentiated mammary acini 192 
To explore the biological consequence of RAB5A-induced endo-ERK1/2 axis, we exploited the 193 
ability of MCF10A cells to generate differentiated, kinetically and proliferation-arrested hollow cysts 194 
grown over Matrigel plugs (Supplementary Figure 7A and ref18). We employed mCherry-H2B-195 
expressing control and RAB5A-cells to monitor the kinematics of differentiated cysts (Figure 4A). 196 
Cells in control differentiated acini were kinetically-arrested, whereas expression of RAB5A 197 
reawakened motility by triggering rotational motion (Figure 4B-C, Supplementary Movie 15). With 198 
custom PIV, we quantified the tangential rotational velocity field and extracted relevant kinematic 199 
parameters, such as the root mean square velocity 𝑣#$% and the rotational order parameter	𝜓, which 200 
can vary between 0 (absence of coordinated motion) and 1 (for a rigidly rotating sphere) (see 201 
Methods). Control acini displayed barely detectable 𝑣#$% , with 𝜓   below 0.2 (Figure 4C, 202 
Supplementary Movies 15-16), whereas following RAB5A-expression 𝜓 reached a value close to 1 203 
in correspondence of the maximum of 𝑣#$%  (Figure 4C, Supplementary Movies 15-16). 204 
 Impairing EGFR activity, ERK1/2 phosphorylation and dynamin-endocytosis reduced 𝑣RMS and 𝜓 205 
to control levels (Figure 4D, Supplementary Movie 17). Additionally, RAB5A-cysts displayed 206 
elevated phosphoERK1/2 (Supplementary Figure 7B) and straight and compact junctions 207 
(Supplementary Figure 7C), indicating that, RAB5A impacts on similar biochemical and microscopic 208 
determinants as in 2D monolayers14.  209 
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 We also noticed that inducing RAB5A expression in the initial phase of cystogenesis reduced the 210 
number of acini, but the ones remaining were significantly larger (Figure 4E-F), and did not undergo 211 
proliferation arrest, like control cysts do, as revealed by Ki67 staining or apoptosis (Supplementary 212 
Figure 7D). Importantly, proliferation was not a pre-requisite for motility, since treatment with 213 
Mitomycin C had no effects on rotations (Supplementary Movie 18). We investigated this phenotype 214 
further by inducing RAB5A expression at the end of morphogenesis, when fully-differentiated acini 215 
have ceased proliferation and motility18. RAB5A expression reawakened not only cell motility 216 
(Supplementary Movie 19) but also proliferation in an ERK1/2-dependent manner (Figure 4G-H).  217 
 The ERK1/2-dependent re-awakening of collective motion and proliferation of terminally-218 
differentiated acini has been associated with the initiation of a more complex program of branched 219 
morphogenesis that begins with the formation of multicellular buds40. This process requires in 220 
addition to specific growth factors, also cell interaction with the microenvironment and ECM 221 
components41, 42. Collagen Type-I, for example, has been used to increase chemo-mechanical 222 
signalling and facilitate duct morphogenesis43. Henceforth, we grew MCF10A cells over mixed 223 
matrigel:collagen gels42. Under these conditions, RAB5A expression caused cysts to lose their 224 
spherical roundness, and promoted the formation of buds (Figure 4I-J).  225 
 226 
Endocytic unjamming promotes carcinoma collective invasion  227 
To determine whether RAB5A-unjamming can be exploited by breast cancer lines to enhance 228 
collective motility and invasiveness, we employed MCF10.DCIS.com cells, which are isogenic to 229 
MCF10A, express oncogenic T24-H-RAS and are used as models for the progression of DCIS to 230 
invasive carcinoma44. During the DCIS phase, cells grow under intra-ductal confinement where cell 231 
packing and density exert mechanical stress and supress tumour motility and progression. 232 
Consistently, MCF10.DCIS.com cells plated as confluent monolayers are kinetically-arrested. 233 
RAB5A expression promoted the reawakening of collective motion (Supplementary Figure 8A, 234 
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Supplementary Movie 20 and ref14), and accelerated wound closure of monolayers, which instead of 235 
arresting after the opposing fronts collided, kept on flowing, reminiscent of “a wound that never 236 
heals45” (Figure 5A-C, Supplementary Movie 21). Biochemically, RAB5A expression decreased total 237 
EGFR levels, but increased ERK1/2 without affecting AKT or p38 phosphorylation (Supplementary 238 
Figure 8B). Next, we monitored the kinematics of mCherry-H2B control and RAB5A-expressing 239 
MCF10.DCIS.com spheroids embedded into native collagen type-I by developing 3D Differential 240 
Variance Analysis (see Methods). Whereas control cells displayed a slow, uncorrelated, disordered 241 
motion (Figure 5D-E, Supplementary Figure 8C, Supplementary Movie 22), RAB5A-242 
MCF10.DCIS.com cells acquired collective rotational motility, characterized by a large angular 243 
velocity  W (of the order of ~12 rad/hr) and a strong orientational persistence of the instantaneous 244 
axis of rotation, captured by the decay time of the orientational correlation function (Figure 5E, 245 
Supplementary Figure 8C). We also observed a speed-up of the local cell rearrangement dynamics, 246 
estimated by calculating the overlap parameter 𝑄(∆𝑡) , which quantifies (see also Methods) the 247 
fraction of nuclei that have been displaced from their original position during a time interval of 248 
duration (∆𝑡, when observed in a reference frame co-moving with the whole spheroid (Figure 5E, 249 
Supplementary Figure 8C). The decay of 𝑄(∆𝑡) does not depend on the rigid motion of the spheroid 250 
as a whole, but captures, instead, the "fluid-like" relative motion of cells. 251 
By repeating the same analysis in a space-resolved fashion (see Methods), we discovered that, for 252 
RAB5A-MCF10.DCIS.com spheroids, the decorrelation rate associated with the decay of the local 253 
overlap parameter displayed a systematic radial dependence, being much larger at the periphery of 254 
the spheroid (Figure 5F-G). The presence of a “melted” layer of cells on the surface of the rotating 255 
spheroid was confirmed by an optical-flow analysis (see Methods) of the velocity fluctuations 256 
(Supplementary Movie 23) that, after removal of the global rotation, exhibited a marked increase 257 
close to the boundaries (Figure 5F-G). 258 
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Endocytic-mediated liquid-like collective rotation in RAB5A-MCF10.DCIS.com spheroids was 259 
dependent on EGFR activity, ERK1/2 phosphorylation, Dynamin-2 and abrogated by inhibiting 260 
ARP2/3-mediated actin polymerization (Supplementary Figure 8C, Supplementary Movie 24). 261 
Furthermore, EM morphological analysis of monolayers, spheroids and orthotopically-injected 262 
tumours revealed that RAB5A expression induces junctional straightening and increases cell-cell 263 
contact areas (Figure 5H). Thus, similar cellular/biochemical processes driving 2D locomotion and 264 
acini morphogenesis control the dynamics of oncogenic epithelial ensembles. 265 
Next, we explored the consequence of endocytic-mediated, unjamming by monitoring oncogenic 266 
spheroids co-expressing EGFP-LifeAct and mCherry-H2B over longer time scales. Invariably, 267 
RAB5A promoted collective angular motion and the formation of invasive, multicellular buds and 268 
strands, suggesting that unjamming and collective invasion might be temporally coordinated and 269 
possibly coupled (Figure 6A-B, Supplementary Movie 25).  270 
Collective invasion into native collagen type-I, which, at the concentration used, form a dense 271 
fibrillar network (Supplementary Figure 8D), can only occur following its remodelling. To verify 272 
this, we exploited fluorescent functionalized-beads that bind to the collagen fibres, impeding relative 273 
motion between beads and the ECM used to embed the spheroids (Figure 6C, Supplementary Movie 274 
26). We developed Stress Fluctuation Microscopy (see Methods) to infer, from the instantaneous 275 
velocity maps of the tracers (Supplementary Movie 27), an estimate of RMS values of the fluctuating 276 
strains induced by the cellular motion onto the ECM. Reconstructed normal RMS stresses are 277 
obtained (Figure 6D-E, Supplementary Movie 27) via the constitutive equations of the material, 278 
whose Young’s modulus 𝐸 = 135 ± 57	𝑃𝑎  was measured using atomic-force microscopy 279 
(Supplementary Figure 8D). The RMS stresses imposed on the matrix by RAB5A-spheroids were 280 
about two times larger than controls (Figure 6E). The corresponding RMS normal strain at the 281 
boundary of RAB5A-expressing cells was of the order of about 10%, well above the critical value 282 
(strain ~ 5-6.5%) at which native collagen gels starts exhibiting a non-linear mechanical response and 283 
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strain-induced remodelling46-48. Consistently, RAB5A-expressing, rotating spheroids extensively 284 
remodelled fibrillary collagen, detected by Second Harmonic Generation (SHG) signals of two-285 
photon illumination, generating gaps and channels (Supplementary Figure 8E). EGFR, ERK1/2, 286 
Dynasore, and ARP2/3 inhibitor of collective angular motion prevented also collagen remodelling 287 
and invasion (Figure 6F).  288 
Next, we extended this finding using ex vivo organotypic tumour slices from m-Cherry-H2B and 289 
EGFP-LifeAct-expressing DCIS orthotopically-injected into immunocompromised mice. Tumour 290 
masses were mechanically excised and grown as organotypic tissue slices at the air-liquid interface 291 
(see methods and ref.49). Whereas control tumours were immobile, jammed and compacted, RAB5A-292 
expressing malignant cells became highly motile and appeared to stream like a flowing liquid 293 
(Supplementary Movie 28) also captured by PIV (Figure 6G-H, Supplementary Movie 29). Thus, 294 
endocytic unjamming of kinetically-arrested DCIS tumours is sufficient to instigate motility and 295 
promote collective invasion.  296 
The pathophysiological relevance of our findings is underscored by the observations that RAB5A 297 
is deregulated in breast cancer13, 50, and specifically during the invasive progression of human ductal 298 
breast carcinomas. Indeed, RAB5A expression was low in malignant cells of densely-packed and 299 
jammed DCIS foci. The percentage of strongly expressing RAB5A cells increased at foci of DCIS 300 
associated with invasive components or in overt infiltrating carcinomas (IDC) (Supplementary Figure 301 
9A). Additionally, RAB5A increased expression was detected in aggressive breast cancer cell lines 302 
(Supplementary Figure 9B), and correlated with worse relapse-free probability in various breast 303 
cancer subtypes (Supplementary Figure 9C).  304 
 305 
Conclusions 306 
We identify a molecular route, which reinstates multicellular rearrangements in otherwise immobile 307 
mature epithelia and densely-packed carcinoma. Biochemically, we showed that elevated RAB5A 308 
 14 
enhances non-clathrin endocytosis of EGFR and promotes its accumulation into endosomal vesicles, 309 
which become signalling platforms for the prolonged and elevated activation of ERK1/2. This, in 310 
turn, is sufficient to promote the hyper-phosphorylation of WAVE2 that, by controlling actin 311 
polymerization, contributes to the extension of oriented, cryptic lamellipodia35. Physically, the latter 312 
protrusions exert increased traction forces14, 51, and enhance cell orientation, promoting flocking in 313 
epithelia monolayers and long-range coordinated rotation in 3D cysts and spheroids. 314 
 Remarkably, RAB5A-expressing spheroids display a radial gradient of fluidity whereby cells at 315 
the periphery in contact with the ECM exhibit faster rearrangement dynamics and increased tissue 316 
fluidization. These kinematic changes are linked to increased strains/stresses exerted on the 317 
surrounding ECM beyond the threshold for remodelling fibrillar collagen46, thereby facilitating to the 318 
generation of tracks and channels into which fluidized cells advance collectively. These mechanical 319 
changes are remarkably reminiscent to the graded unjamming (solid-to-fluid) transition observed 320 
along the body axis of developing zebrafish embryo and shown to drive body axis elongation52. They 321 
further point to the concept that spatio-temporal control of fluid-like and solid-like tissue states, and 322 
graded fluidization specifically, might be a general physical mechanism of diverse multicellular 323 
collectives. This mechanism might emerge as an adaptive “smart material” strategy of cell collectives 324 
in responses to variation in the chemical/mechanical composition of the ECM and further impacts on 325 
the structural composition of surrounding stroma. Within this context, the transition from DCIS, 326 
which grow under intra-ductal confinement where extreme cell packing and density exert mechanical 327 
stress and supress motility, to invasive carcinoma, which disperse locally also through collective 328 
invasion53, represents a case in point.  329 
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Methods 330 
Methods and any associated accession codes and references are included after the references.  331 
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Figure 1. Endocytic reawakening of motility is dependent on EGFR activation 363 
A. PIV analysis of motion of control and RAB5A-expressing-MCF10A monolayers in the presence 364 
or the absence of EGF (Supplementary Movies 1 and 3) or the EGFR inhibitor AG1478 365 
(Supplementary Movie 2). Vertical lines indicate the time interval used for the analysis of motility 366 
parameters: 	𝑣#$% = 5〈|𝒗|𝟐〉 : root mean square velocity; 𝐶<<:	velocity correlation functions as 367 
function of the distance 𝑟; Lcorr: correlation lengths; 𝑀𝑆𝐷: mean square displacements obtained by 368 
numerical integration of the velocity maps over a given time interval, Δt.; Lpers, persistence length. 369 
Data are from at least 5 movies/experimental conditions in 4 experiments.  370 
B. Snapshots of the velocity field obtained from PIV analysis of motion of control (CTR) and 371 
RAB5A-MCF-10A monolayers treated as indicted (Supplementary Movie 4). The colour-map 372 
represents the alignment with respect to the mean instantaneous velocity, quantified by the parameter 373 𝑎(𝑥) = (𝒗(𝑥) ∙ 𝒗D) (|𝒗(𝑥)||𝒗D|)⁄ 	 . 𝑎 = 1(−1)  when the local velocity is parallel (antiparallel) to the 374 
mean direction of migration. Bar, 100 µm. 375 
C. Immunoblot of the indicated proteins and quantification of total EGFR and phosphorylated/total 376 
EGFR value. Data are expressed relative to control after normalizing to Vinculin (mean±SD, n=5 377 
independent experiments)  378 
D. Relative EGFR mRNA levels normalized to GAPDH (mean±SD, n=5 independent experiments).  379 
E. Control and RAB5A-MCF10A were either permeabilized or non-permeabilized with 0.1% Triton 380 
X100 before staining.  381 
F. Data are mean±SD of total cell surface or internalized EGFR relative to control normalized to cell 382 
number (n = 100 cells in 3 independent experiments). Bar, 20 µm. 383 
G. Images of control and RAB5A-MCF10A monolayers stained with the indicated abs. Data are the 384 
mean±SD of EEA1 and EGFR-positive vesicles/cells (n>150 out of 3 independent experiments). Bar, 385 
20 µm 386 
 19 
H. Number of EGFR/cell measured by 125I-EGF saturation binding after subtracting unspecific 387 
background. Data are the mean±SD of triplicate measurements.  388 
**p < 0.01, ***p < 0.001, each-pair Student’s t-test. 389 
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390 
Figure 2. RAB5A increases non-Clathrin internalization of EGFR. 391 
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A. Effective or apparent internalization rate constants at low (1 ng/ml) or high (30 ng/ml) 392 
concentrations 125I-EGF, respectively (Ke, upper panel) in control and RAB5A-expressing 393 
monolayers. A representative kinetic of the ratio of 125I-EGF internalized/bound is shown and is 394 
expressed as the mean±SD (n=3 out of 12 independent experiments). ****p <0.0001.  P values, each-395 
pair Student’s t-test. 396 
B.  Control or RAB5A-MCF10A cells monolayers were incubated with 125I-EGF (30 ng/ml) for 15 397 
min at 37 ˚C. Recycling of 125I-EGF at the indicated time points was estimated as described in 398 
Methods. Data are the mean ± SD (n = 3 replicates in a representative experiment).  399 
C. EGFR internalization kinetic in control and RAB5A-expressing monolayers silenced for 400 
Dynamin-2 (DNM2), Clathrin heavy chain (CLTC) or Reticulon 3 (RTN3) using 125I-EGF at high 401 
(30 ng/ml) concentrations. Results are the mean±SD (n=3 independent experiments) of the apparent 402 
internalization rate constants, Ke. **p <0.01. P values, each-pair Student’s t-test (the comparison 403 
between paired values is indicated). See Supplementary Table 2 for additional statistics. 404 
D. The effectiveness of silencing was measured by QRT-PCR. Data are expressed relative to control 405 
after normalizing to GAPDH. The data are the relative level of gene expression compared to control 406 
expressed as mean ± SD (n=3 independent experiments). ** p < 0.01, P values, each-pair Student’s 407 
t-test (siRNA vs control). 408 
E. EGFR internalization kinetic in control and RAB5A-expressing cells monolayers treated with 409 
vehicle or 5-(N-ethyl-Nisopropyl) amiloride (EIPA) (75 µM) was measured using 125I-EGF at high 410 
(30 ng/ml) concentrations. Results are mean±SD (n=3 independent experiments) of the apparent 411 
internalization rate constants, Ke. *p <0.05**, p <0.01.  P values, each-pair Student’s t-test (the 412 
comparison between each paired value is indicated).  413 
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Figure 3. RAB5A endosomal ERK1/2 activity is required for flocking locomotion  415 
A. Immunoblot of control and RAB5A-MCF10A monolayers with the indicated abs. The ratio of 416 
phosphorylated/total levels of the indicated proteins is expressed mean±SD (n=5 independent 417 
experiments). 418 
B. PIV analysis of motion (Supplementary Movie 8) of control and RAB5A-MCF10A monolayers 419 
treated with vehicle or PD0325901 (1 µM), a MEK inhibitor to extract: root mean square velocity 420 	𝑉#$% = 5〈|𝒗|𝟐〉, correlation length 𝐿JKLL and persistence length 𝐿MNLO. Data are the mean±SD (n=5 421 
movies/ conditions out of 3 independent experiments).  422 
C. Immunoblot of control and RAB5A-MCF10A monolayers treated with PD0325901, or AG1478, 423 
or Dynasore (80 µM) or vehicle as control with the indicated abs. The ratio of 424 
phosphoERK1/2/totalERK1/2 is expressed as mean±SD (n=4 independent experiments).  425 
D-E. Still phase-contrast and fluorescent images of cryptic lamellipodia in control and RAB5A-MCF-426 
10A monolayers composed of mosaically GFP-LifeAct-expressing (green):non-expressing cells 427 
(1:10 ratio) from Supplementary Movie 11. Examples of the fluctuation of cell contours at 0’-green, 428 
45’-red, 90’-indaco (ADAPT Mask). Bars, 20 µm. In E, Number of cells with lamellipodium and 429 
velocity of protrusion fluctuation are expressed as mean±SD. (n=65 cells/conditions from 4 430 
independent experiments).  431 
F. Immunoblotting of control and RAB5A-MCF10A cells monolayers silenced for the critical WAVE 432 
complex component, NAP1. 433 
G. Analysis of the dynamics of cell protrusions of mosaically-expressing GFP-lifeAct, control and 434 
RAB5A-MCF10A monolayers silenced for the critical WAVE complex component, NAP1, 435 
Supplementary Movie 12. The velocity of protrusion fluctuation is the mean±SD (n=96 436 
cells/conditions from 3 independent experiments).  437 
H. PIV analysis of motion (Supplementary Movie 13) of control and RAB5A-MCF10A monolayers 438 
silenced for the critical WAVE complex component, NAP1, to extract: root mean square velocity 439 
 24 
	𝑉#$% = 5〈|𝒗|𝟐〉, correlation length 𝐿JKLL and persistence length 𝐿MNLO. Data are the mean±SD (n=5 440 
movies/ conditions out of 3 independent experiments).  441 
*p < 0.01, ****p < 0.0001, P values, each-pair Student’s t-test. 442 
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Figure 4. RAB5A overcomes kinetic and proliferation arrest in terminally-differentiated acini. 447 
A-C. Single Z planes from Supplementary Movie 15 of control and RAB5A-MCF10A-expressing 448 
mCherry-H2B acini. RAB5A mRNA levels relative to control after normalizing to GAPDH are 449 
shown as mean±SD (n=3 independent experiments). Bar, 50 µm. In B, Tangential velocity fields at 𝑡 450 
= 10 h (yellow arrows) from PIV analysis, overlaid on radial projection of acini onto a unit spherical 451 
surface (Supplementary Movie 16). The red arrow is parallel to the instantaneous total angular 452 
momentum 𝒍 and provides the orientation of the instantaneous axis of rotation. Its length is equal to 453 
the instantaneous order parameter 𝜓. In C, Time evolution of root mean square velocity 	𝑣#$% and 454 
rotational order parameter 𝜓 (see text and Methods) representative of 4 movies in 3 experiments. 455 
D. 	𝑉#$% = 5〈|𝒗|𝟐〉 and of  𝜓, calculated over the 4-to-12 h (Supplementary Movie 17) time window 456 
for control and RAB5A-MCF-10A mcherry-H2B- expressing MCF10A acini treated as indicated. 457 
Average values are from 5 movies in 3 independent experiments.  458 
E. Control and RAB5A-MCF10A acini treated as indicated above were processed for phase contrast 459 
imaging to monitor acini shape and size (left images). Bar, 100 µm.   460 
F. Acini size expressed as the mean±SD (n=100 acini/conditions in 5 independent experiments).  461 
G. IF images of control and RAB5A-MCF10A acini treated with doxycycline as indicated in the 462 
presence or absence of PD0325901. Bar, 80 µm.  463 
H. Acini diameter and the number of KI67+ cells/ total number of cells/ acini is reported as 464 
means±SD (n=25 acini/conditions in 3 independent experiments).  465 
I. Control and RAB5A-MCF10A acini grown on mixed 1:1=Matrigel:Collagen Type-I plugs for 21 466 
days were processed for phase contrast imaging. Bar, 100 µm. 467 
J. Acini area and roundness is expressed as mean±SD (n=40 acini/conditions in 5 experiments).  468 
*p<0.05, ** p < 0.01.  P values, each-pair Student’s t-test.   469 
 470 
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Figure 5. RAB5A promotes the emergence of coordinated angular rotation in cancer spheroids  472 
A-C. Stills of scratched wound migration in control and RAB5A-MCF10.DCIS.com monolayers. 473 
Dashed lines mark the wound edges. Bar, 100 µm. Motility (Supplementary Movie 21) was quantified 474 
as (B) the percentage of area covered or (C) 	𝑉#$% = 5〈|𝒗|𝟐〉. Vertical bars indicate the time at which 475 
wounds closed. Data are representative of 1 experiment out of >10. 476 
D-E. Snapshots of mCherry-H2B-expressing, control and RAB5A-MCF10.DCIS.com spheroids 477 
embedded in Collagen Type-I (6.0 mg/ml). Bar, 100 µm. E. Image Differential Variance-based 478 
Analysis (3D DVA) of 5-8 spheroid/conditions in 3 independent experiments (Methods and 479 
Supplementary Movie 22) was performed to extract: the angular velocity Ω (rad/hr); the angular 480 
correlation of motion quantified by considering the decay of the orientational correlation function; 481 
the overlap parameter 𝑄  captured from the non-rigid part of motion, involving mutual cell 482 
rearrangement and fluid-like dynamics. 483 
F-G. Maps of the RMS velocity fluctuations on the equatorial plane of a CTR and RAB5A-expressing 484 
spheroid. Bar, 100 µm. In G, azimuthally averaged radial profiles of the relaxation rate Γ, for CTR 485 
and RAB5A spheroids, obtained with 3D DVA analysis (Supplementary Movie 23). Curves are 486 
scaled along the x axis with the radius 𝑟D of each spheroid and along the y axis with the value of the 487 
relaxation rate Γ(0) at the center of spheroid. Thick curves represent the average value with peacks 488 
at 1.2±01 and 1.6±0.2. (n=7 for each condition). p<0.05, each-paired Student’s t-test. 489 
H. Electron microscopy of control and RAB5A-MCF10.DCIS.com monolayers, or 3D spheroids, or 490 
tumor orthotopically injected into immune-compromised mice. Blue arrows point to cell–cell contact 491 
spaces, red arrows to tight cell–cell contacts. Bar, 2 µm. The average distance between adjacent cells 492 
is reported below as mean±SD (n=35 cell-cell junction in random fields in 3 experiments). **** p < 493 
0.001. P values, each-pair Student’s t-test. 494 
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Figure 6. RAB5A promotes collective invasion in tumour spheroids and tumours slices 496 
A-B. Invasive structures in EGFP-LifeAct and mCherry-H2B-co-expressing control and RAB5A-497 
MCF10.DCIS.com spheroids embedded in Collagen Type-I (Supplementary Movie 25). The line 498 
delineates an invasive multicellular bud; the arrow points to an invasive strand. The percentage of 499 
spheroids with invasive structures is expressed as mean±SD (n=15/experimental conditions in 5 500 
independent experiments). ** p<0.01, each-paired Student’s t-test Bar, 150 µm. 501 
C. Snapshots (Supplementary Movie 26) of mCherry-H2B-expressing control and RAB5A-502 
MCF10.DCIS.com spheroids embedded in Collagen Type-I interspersed with functionalized 503 
fluorescent-beads (Fluo-beads). Bar, 200 µm. 504 
D. Maps of RMS normal stresses on ECM in the equatorial plane of CTR and RAB5A-expressing 505 
spheroids, respectively (Supplementary Movie 27). 506 
E. Azimuthally averaged radial profiles of the RMS normal stress/strain for CTR and RAB5A-507 
spheroids. Curves are scaled along the x axis with the radius 𝑟D of each spheroid. Thick curves are 508 
the average of analyzed spheroids. The shaded region corresponds to the critical strain above which 509 
Collagen undergoes strain-induced structural remodelling and non-linear mechanical response46. p < 510 
0.01, pair Student’s t-test. 511 
F. SHG analysis of Collagen type-I fibres used to embed mCherry-H2B-expressing control and 512 
RAB5A-MCF10.DCIS.com spheroids in the presence of vehicle or the indicated inhibitors. The % 513 
of spheroids with invasive structures is expressed as mean±SD (n=15/experimental conditions in 5 514 
independent experiments). ** p<0.01, each-pair Student’s t-test. Bar, 70 µm. 515 
G-H. Experimental scheme: EGFP-LifeAct and mCherry-H2B-expressing control and RAB5A-516 
MCF10.DCIS.com DCIS orthotopically-injected into immunocompromised mice were mechanically 517 
excised and placed at the air-liquid interface, and monitored by time-lapse (Supplementary Movie 518 
28). PIV analysis to extract the cellular root mean square velocity, 	𝑉#$% =519 5〈|𝒗|𝟐〉	(Supplementary	Movie	29). Boxed areas indicate fields of view for the analysis (At least 5 520 
 31 
field of view/movie for 3 independent experiments). Bar, 150 µm. In H, thick lines are averages of 521 
the time-dependent 	𝑉#$% for each field of view (thin lines) in CTR and RAB5A, respectively. 522 
 523 
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METHODS 644 
 645 
Plasmids, antibodies and reagents. 646 
Doxycycline-inducible lentiviral vectors pSLIK-neomycin (neo) carrying RAB5A or RAB5C 647 
sequences and pSLIK-hygromycin (hygro) carrying RAB5B sequence were obtained by Gataway 648 
Technology (Invitrogen), following the manufacturer’s protocol. The plasmids pBABE-puromycin 649 
(puro)-mCHERRY-H2B and pBABE- puro-EGFP-H2B were provided by IFOM-Imaging Facility. 650 
The lentiviral expression construct pRRL-Lifeact-EGFP-puromicin (puro) was a gift of Olivier Pertz 651 
(University of Basel, Basel, Switzerland). pBabe-Puro-MEK-S218D/S222D (MEK-DD) vector was 652 
purchased from Addgene. 653 
FRET EKAREV-ERK1/2 sensor53 was generated by cloning synthetized FYVE domain of SARA 654 
into the BamHI/EcoRI cleaved EKAREV-FRET vector to generate pPBbsr2-3560NES-EKAREV-655 
FRET vector. 656 
Mouse monoclonal antibodies raised against α−tubulin (#T5168) or vinculin (#V9131) were from 657 
Sigma-Aldrich (dilution 1:400). Rabbit polyclonal anti-RAB5A (S-19, #sc-309) and goat polyclonal 658 
anti-EEA-1 (N-19, #sc-6415) antibodies from Santa Cruz Biotechnology (Dilution 1:400). 659 
Monoclonal rabbit anti-human RAB5A - ab109534, dilution 1:100, (Abcam[EPR5438]) was used of 660 
IHC;Rabbit polyclonal anti-Giantin (#PRB-114C) antibody was from Covance. Mouse monoclonal 661 
anti-human Ki-67 Antigen (MIB-1, #M7240) antibody was from Dako (1:1000). Mouse monoclonal 662 
anti-AP50 (AP2mu) (31/AP50, #611350) was from BD Bioscience. Mouse monoclonal anti-E-663 
cadherin (#610181) antibody was from Transduction Lab (Dilution 1:1000). Rabbit polyclonal anti-664 
phospho-EGFR (Tyr1086, #2220), rabbit monoclonal anti-phospho-p44/42 MAPK (ERK1/2) 665 
(Thr202/Tyr204, #4370), rabbit polyclonal anti-p44/42 MAPK (ERK1/2) (#9102), rabbit monoclonal 666 
anti-phospho-p38 MAPK (Thr180/Tyr182, 3D7, #9215), mouse monoclonal anti-p38 MAPK 667 
(L53F8, #9228), rabbit monoclonal anti-phospho-AKT (Ser473, 193H12, #4058), rabbit polyclonal 668 
anti-AKT (#9272), rabbit polyclonal anti-MEK1/2 (#9122) and rabbit polyclonal anti-cleaved 669 
 35 
Caspase-3 (Asp175, #9661) antibodies were from Cell Signalling Technology (Dilution 1:1000). 670 
Rabbit polyclonal anti-phospho-WAVE2 (Ser343, #07-1512), rabbit polyclonal anti-phospho-671 
WAVE2 (Ser351, #07-1514) and mouse monoclonal anti-Laminin-V (P3H9-2, #MAB1947) 672 
antibodies were from Merck/Millipore (Dilution 1:500). Mouse monoclonal anti-WAVE2 and mouse 673 
monoclonal anti-ABI1 antibodies were homemade54 (Dilution 1:100). Rabbit polyclonal anti-NAP1 674 
antibody was a gift of Theresia Stradal (Helmholtz Centre for Infection Research, Braunschweig, 675 
Germany)55. Rabbit polyclonal anti EGFR (806), directed against aa 1172-1186 of human EGFR 676 
(ImmunoBlot) and mouse monoclonal anti-EGFR (m108 hybridoma) directed against the 677 
extracellular domain of human EGFR (IF) were a gift from P.P. Di Fiore (Dilution 1:1000). 678 
Secondary antibodies conjugated to horseradish peroxidase were all used at dilution 1:2000 and were 679 
from: Bio-Rad (#7074, #7076); Cy3-secondary antibodies from Jackson ImmunoResearch (#711-680 
165-152, #715-165-150); DAPI (#D-1306) and AlexaFluor 488 (A-11055, A-21202) were from 681 
Thermo Fisher Scientific. TRITC- (#P1951) and FITC-(#P5282) conjugated phalloidin were from 682 
Sigma Aldrich.  683 
Doxycycline Hyclate (DOX, #D9891), Dynasore Hydrate (#D7693), AG1478 (#T4182), 5-(N-Ethyl-684 
N-isopropyl)amiloride (#1154-25-2) and CK666 (#SML0006) were from Sigma Aldrich. PD0325901 685 
(#444966) was from Merck/Millipore. SCH772984 (#942183-80-4) was from Selleckchem. 686 
FluoSpheres™ Sulfate Microspheres, 0.2 µm yellow-green fluorescent (505/515), 2% solids 687 
(#F8848) were from ThermoFisher. Mitomycin C (#M0503) from Sigma Aldrich. 688 
 689 
Cell cultures and transfection. 690 
MCF10A cells were a kind gift of J. S. Brugge (Department of Cell Biology, Harvard Medical School, 691 
Boston, USA) and were maintained in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 692 
(DMEM/F12) medium (Biowest) supplemented with 5% horse serum, 1% L-Glutamine (EuroClone), 693 
0.5 mg ml−1hydrocortisone (Sigma-Aldrich), 100 ng ml−1 cholera toxin (Sigma-Aldrich), 694 
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10 µg ml−1 insulin (Sigma-Aldrich) and 20 ng ml−1 EGF (Vinci Biochem). MCF10.DCIS.com cells 695 
were kindly provided by J. F. Marshall (Barts Cancer Institute, Queen Mary University of London, 696 
UK) and maintained in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12) 697 
medium supplemented with 5% horse serum, 1% L-Glutamine, 0.5 mg ml−1hydrocortisone, 698 
10 µg ml−1 insulin and 20 ng ml−1 EGF. All cell lines have been authenticated by cell fingerprinting 699 
and tested for mycoplasma contamination. Cells were grown at 37 °C in humidified atmosphere with 700 
5% CO2. Phoenix-AMPHO (ATCC® CRL-3213™) were used as packaging cell line for the 701 
generation of retroviral particles and cultured as recommended by the supplier. HEK293T were 702 
obtained from BBCF-Biological Bank and Cell factory, INT, Milan grown in DMEM, 10% foetal 703 
bovine serum, 2mM L-Glutamine and used as packaging line for lentiviral vectors. MCF10A cells 704 
were infected with pSLIK-neo-EV (empty vector-CTR), pSLIK-neo-RAB5A, pSLIK-hygro-RAB5B 705 
or pSLIK-neo-RAB5C lentiviruses and selected with the appropriate antibiotic to obtain stable 706 
inducible cell lines. MCF10.DCIS.com were infected with pSLIK-neo-EV (empty vector-CTR) or 707 
pSLIK-neo-RAB5A lentiviruses and selected with the appropriate antibiotic to obtain stable inducible 708 
cell lines.  Constitutive expression of EGFP-LifeAct- or mCHERRY- or EGFP-H2B was achieved 709 
by lentiviral and retroviral infection of MCF10A and MCF10DCIS.com cells with EGFP-LifeAct- 710 
puro or pBABE- puro-mCHERRY-H2B/ pBABE- puro-EGFP-H2B vectors, respectively. 711 
Transfections were performed using either calcium phosphate or FUGENE HD Transfection reagent 712 
(#E2311, PROMEGA) reagents, according to manufacturer’s instructions. FUGENE HD reagent was 713 
used for FRET-EKAREV-ERK1/2 transfection in MCF10A cells. 714 
 715 
Generation of lentiviral and retroviral particles  716 
Packaging of lentiviruses or retroviruses was performed following standard protocols. Viral 717 
supernatants were collected and filtered through 0.45 µm filters. Cells were subjected to four cycles 718 
of infection and selected using the appropriate antibiotic: neomycin for pSLIK-neo vector (150 719 
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µg/ml), hygromycin for pSLIK-hygro vector (100 µg/ml) or puromycin for EGFP-LifeAct or pBABE 720 
vectors (2 µg/ml). After several passages, stable bulk populations were selected and induced by 721 
Doxycycline Hyclate (2.5 µg/ml) in order to test: i) induction efficiency by Western Blotting and 722 
quantitative RT-PCR (qRT-PCR), and ii) the homogeneity of the cell pool by immunofluorescence 723 
staining, as previously shown56.  724 
 725 
RNA interference 726 
siRNAs (small interfering RNAs) delivery was achieved by mixing 1 nM of specific siRNAs with 727 
Optimem and Lipofectamine RNAiMAX Transfection Reagent (Life Technologies). The first cycle 728 
of interference (reverse transfection) was performed on cells in suspension. The day after, a second 729 
cycle of interference (forward transfection) was performed on cells in adhesion. The following 730 
siRNAs were used for knocking down specific genes. All sequences are 5’ to 3’.  731 
Dynamin2 (DNM2): 5’-GACATGATCCTGCAGTTCA-3’ (Dharmacon) 732 
Clathrin heavy chain (CLTC): 5'-UAAAUUUCCGGGCAAAGAGCCCCC-3' (Riboxx) 733 
NCKAP1 (NAP1):  5’-CUCGAAAUCUCAUCACUGATT-3’ (Silencer Select, Ambion) 734 
WASF4 (WAVE2): 5’-AGACCCUUCAUACUUCUUUTT-3’ (Silencer Select, Ambion) 735 
Reticulon 3 (RTN3) (Smart pool, Dharmacon):    736 
5’-CAAUAUGAGAAUUCAGCGA-3’ 737 
      5’-GGAAAUUGUCUACGUGUCU-3’ 738 
5’-GGGAAUAUGCACUGGCGAG-3’ 739 
5’-AAGGAAAGGCUCCGCCAUU-3’  740 
Reticulon 3 (RTN3): 5'-CCCUGAAACUCAUUAUUCGUCUCUU-3' (Stealth, Invitrogen) 741 
Reticulon 4 (RTN4): 5'-CCAGCCUAUUCCUGCUGCUUUCAUU-3' (Stealth, Invitrogen) 742 
For each RNA interference experiment, negative control was performed with the same amount of 743 
scrambled siRNAs. Silencing efficiency was controlled by qRT-PCR. 744 
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 745 
Quantitative RT-PCR analysis  746 
Quantitative RT-PCR analysis was performed as previously shown56. Total RNA was extracted using 747 
RNeasy Mini kit (Qiagen) and quantified by NanoDrop to assess both concentration and quality of 748 
the samples. Reverse transcription was performed using SuperScript VILO cDNA Synthesis kit from 749 
Invitrogen. Gene expression was analyzed using TaqMan Gene expression Assay (Applied 750 
Biosystems). 0.1 ng of cDNA was amplified, in triplicate, in a reaction volume of 25 µl with 10 pMol 751 
of each gene- specific primer and the SYBR-green PCR MasterMix (Applied Biosystems). Real-time 752 
PCR was performed on the 14 ABI/Prism 7700 Sequence Detector System (PerkinElmer/Applied 753 
Biosystems), using a pre-PCR step of 10 min at 95°C, followed by 40 cycles of 15 s at 95°C and 60 754 
s at 60°C. Specificity of the amplified products was confirmed by melting curve analysis 755 
(Dissociation Curve TM; PerkinElmer/Applied Biosystems) and by 6% PAGE. Preparations with 756 
RNA template without reverse transcription were used as negative controls. Samples were amplified 757 
with primers for each gene (for details see the Q-PCR primer list below) and GAPDH as a 758 
housekeeping gene. The Ct values were normalized to the GAPDH curve. PCR experiments were 759 
performed in triplicate and standard deviations calculated and displayed as error bars. Primer assay 760 
IDs were: GAPDH, Hs99999905_m1; RAB5A, Hs00702360_s1; RAB5B, Hs00161184_m1 and 761 
RAB5C, Hs00428044_m1, Dynamin2 (DNM2) Hs00974698_m1, Clathrin heavy chain (CLTC) 762 
Hs00964480_m1, NAP1 Hs00980236_m1, WAVE2 Hs00819075_gh, Reticulon3 (RTN3) 763 
Hs01581965_m1, Reticulon4 (RTN4) Hs01103689_m1. 764 
 765 
Immunoblotting  766 
For protein extraction, cells, previously washed with cold PBS, were lysed in JS buffer supplemented 767 
with proteases and phosphatases inhibitors [50 mM HEPES PH 7.5, 50 mM NaCl, 1% glycerol; 1% 768 
Triton X-100, 1.5 mM MgCl2. 5 mM EGTA plus protease inhibitor cocktail (Roche, Basel, 769 
 39 
Switzerland), 1 mM DTT, 20 mM Na pyrophosphate pH 7.5, 50 mM NaF, 0.5 M Na-vanadate in 770 
HEPES pH 7.5 to inhibit phosphatases]. Lysates were incubated on ice for 10 minutes and cleared by 771 
centrifugation at 13,000 rpm for 30 min at 4°C. Protein concentration was quantified by Bradford 772 
colorimetric protein assay. The same amount of protein lysates was loaded onto polyacrylamide gel 773 
in 5X SDS sample buffer. Proteins were transferred onto Protran Nitrocellulose Transfer membrane 774 
(Whatman), probed with the appropriate antibodies and visualized with ECL western blotting 775 
detection reagents (GE Healthcare). Membrane blocking and incubation in primary or secondary 776 
antibodies were performed for 1h in TBS/0.1% Tween/5% milk for antibodies recognizing the total 777 
proteins or in TBS/0.1% Tween/5% BSA for antibodies recognizing phosphorylated proteins.  778 
Uncropped gels of the main immunoblots are presented in Supplementary Figure 11 and 12.  779 
 780 
Immunohistochemistry on DCIS and IDC 781 
Sections from archival human breast cancer samples were collected from the archives of the Tumor 782 
Immunology Laboratory of the Human Pathology Section, Department of Health Sciences, 783 
University of Palermo, Italy. 784 
Immunohistochemistry was performed using a polymer detection method (Novolink Polymer 785 
Detection Systems Novocastra, Leica Biosystems, Newcastle, Product No: RE7280-K). 786 
Tissue samples were fixed in 10% buffered formalin and embedded in paraffin. Four-micrometers-787 
thick tissue sections were dewaxed and rehydrated. The antigen unmasking technique was performed 788 
using Novocastra Epitope Retrieval Solution pH6 citrate-based buffer in thermostatic water bath at 789 
98°C for 30 minutes. Subsequently, the sections were brought to room temperature and washed in 790 
PBS-Tween. After neutralization of the endogenous peroxidases with 3% H2O2 and protein blocking 791 
by a specific protein block, the samples were incubated 1h with monoclonal rabbit anti-human 792 
RAB5A [EPR5438] - ab109534 (dilution 1:100, Abcam). Staining was revealed by polymer detection 793 
kit (Novocastra, Ltd) and AEC (3-Amino-9-Ethylcarbazole) substrate chromogen. The slides were 794 
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counterstained with Harris hematoxylin (Novocastra, Ltd). All the sections were analyzed under a 795 
Zeiss Axio Scope A1 optical microscope (Zeiss, Germany) and microphotographs were collected 796 
using an Axiocam 503 Color digital camera with the ZEN2 imaging software (blue edition) (Zeiss 797 
Germany). 798 
For quantitative analysis of RAB5A IHC, non-overlapping areas, each corresponding to a x400 high-799 
power microscopic field, were selected from digital slide scans obtained using an Aperio CS2 slide 800 
scanner (Leica Microsystems). A total of 80 fields corresponding to DCIS fields, fields with in situ 801 
and associated infiltrating foci, and overtly-infiltrative IDC fields were analysed. The percentage of 802 
strong positive cells (+3 score) per field was determined using the Aperio ImageScope software and 803 
the Positive Pixel Count v9 Algorithm (Leica Microsystems). 804 
 805 
In situ mRNA hybridization on DCIS and IDC 806 
In situ mRNA hybridization for RAB5A transcript was performed on four micrometers thick FFPE 807 
sections relative to DCIS and IDC. The RNAscope 2.0 HD Reagent Kit (Advanced Cell Diagnostics, 808 
Hayward, CA, USA) was adopted according to the manufacturer’s instructions, using an ad-hoc-809 
designed RAB5A-specific probe (C1 Custom Probe-Hs-RAB5A (targeting 424-2098 of 810 
NM_001292048.1).  811 
All the slides were analyzed under a Zeiss Axio Scope A1 optical microscope (Zeiss, Germany) and 812 
microphotographs were collected using an Axiocam 503 Color digital camera with the ZEN2 imaging 813 
software (Zeiss Germany). 814 
 815 
Cell streaming and wound healing assays 816 
As previously shown56, cells were seeded in 6-well plate (1.5*106 cells/well) in complete medium 817 
and cultured until a uniform monolayer had formed. RAB5A expression was induced, were indicated, 818 
16 hours before performing the experiment by adding fresh complete media supplemented with 2.5 819 
µg/ml Doxycycline Hyclate to cells. Comparable cell confluence was tested by taking pictures by 820 
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differential interference contrast (DIC) imaging using a 10x objective and counting the number of 821 
nuclei/field.  In cell streaming assay, medium has been refreshed before starting imaging. In wound 822 
healing assay, cells monolayer was scratched with a pipette tip and carefully washed with 1X PBS to 823 
remove floating cells and create a cell-free wound area. The closure of the wound was monitored by 824 
time-lapse. Olympus ScanR inverted microscope with 10x objective was used to take pictures every 825 
5-10 minutes over a 24 hours period (as indicated in the figure legends). The assay was performed 826 
using an environmental microscope incubator set to 37°C and 5% CO2 perfusion. After cell induction, 827 
Doxycycline Hyclate was maintained in the media for the total duration of the time-lapse experiment. 828 
The percentage of area covered by cells (area coverage %) overtime and wound front speed were 829 
calculated by MatLab software. In chemical inhibitors experiments, the inhibitor was added together 830 
with Doxycycline Hyclate in fresh media 1 h before starting imaging. For cell streaming assay 831 
performed on interfered cells, cells were interfered in suspension (first cycle) and directly plated at 832 
the desired concentration, following the same conditions already described in “RNA interference” 833 
section.  834 
For detection of cryptic lamellipodia, MCF10A cells stably expressing EGFP-LifeAct were mixed in 835 
a 1:10 ratio with unlabelled cells and seeded in cell streaming assay, as described before. Cell 836 
migration was monitored by time-lapse phase contrast and fluorescence microscopy, collecting 837 
images at multiple stage positions in each time loop. Olympus ScanR inverted microscope with 20x 838 
objective (+1.6x Optovar) or with a Leica AM TIRF MC mic with HCX PL APO 63X/1.47NA 839 
objective and equipped with Andor iXon DU-8285_VP was used to take pictures every 90 seconds.  840 
For protrusion velocity analysis, the morphodynamic quantification was performed using the ImageJ 841 
plugin ADAP (automated detection and analysis of protrusion) 57. 842 
Each assay was done 5 times and at least 25 cells/condition were counted in each experiment. Where 843 
indicated, PD0325901 or SCH772984 was added 1 h before imaging. 844 
 845 
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FRET Analysis 846 
Using a customised macro in ImageJ, FRET data were analysed using the ratiometric approach. CFP, 847 
YFP and FRET images were background subtracted, converted in 32bits and the smoothed YFP 848 
image were tresholded and used as a mask to highlight the vesicular-like structures of interest. On 849 
these areas the average FRET/CFP ratio was then calculated as described in Kardash E. et al. 58 850 
 851 
3D morphogenesis assay 852 
MCF10A morphogenesis assay was per formed as already described67. Briefly, MCF10A cells were 853 
trypsinized and resuspended in MCF10A culture medium. Eight-well chamber slides (#80826 IBIDI) 854 
were coated with 40 µl/well of Growth Factor Reduced Matrigel Matrix Basement Membrane HC 855 
10.2 mg/ml (#354263, Corning) or with 1:1 mixture of Matrigel HC 10.2 mg/ml and Type I Bovine 856 
Collagen 3 mg/ml (#5005 Advanced BioMatrix). Once the matrix is polymerized, 2.5*103 cells were 857 
plated into each well on the top of the matrix layer in culture medium supplemented with 2% Matrigel 858 
HC 10.2 mg/ml and 5 ng/ml EGF. Complete acini morphogenesis was allowed by incubating the cells 859 
for 3 weeks and replacing assay media every four days. 860 
On day 21 acini were treated with 2.5 µg/ml Doxycycline Hyclate to induce RAB5A expression. 861 
Cells were maintained under stimulation for 6 days, changing the medium every 2 days, before 862 
fixation with 4% paraformaldehyde (PFA) and stained with specific antibodies. When inhibitors were 863 
used, the media were refreshed every day. 864 
 865 
3D spheroid kinematic assay 866 
MCF10DCIS.com cells were plated on Ultra-Low attachment surface 6-well plate (#3471 867 
CORNING) at a density of 5*103 cells/well. Cells were grown in serum-free condition for 10 days 868 
by adding fresh culture media every 2 days. Then every single well of spheres were collected and 869 
resuspended in 150 µl of 6 mg/ml Collagen Type I (#35429 CORNING), diluted in culture media, 50 870 
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mM Hepes, 0,12 NaHCO3 and 5 mM NaOH. The unpolymerized mix sphere/collagen was placed in 871 
Eight-well chamber slides and incubated at 37°C for o/n. The day after, before imaging, 2.5µg/ml 872 
Doxycycline Hyclate was added over the polymerized collagen mix to induce RAB5A expression. 873 
For collagen mechanical stress analysis, 20 µl of FluoSpheres™ Sulfate Microspheres, 0.2 µm 874 
(#F8848 ThermoFisher) were added to the unpolymerized mix sphere/collagen and the protocol was 875 
carried out following the same conditions previously described.  876 
 877 
Ex Vivo DCIS tumor slice motility assay 878 
All animal experiments were approved by the OPBA (Organisms for the well-being of the animal) of 879 
IFOM and Cogentech. All experiments complied with national guidelines and legislation for animal 880 
experimentation. All mice were bred and maintained under specific pathogen-free conditions in our 881 
animal facilities at Cogentech Consortium at the FIRC Institute of Molecular Oncology Foundation 882 
and at the European Institute of Oncology in Milan, under the authorization from the Italian Ministry 883 
of Health (Autorizzazione N° 604-2016). 884 
For mammary fat pad tumor development in NSG mice MCF10DCIS.com cells were trypsin 885 
detached, washed twice, and resuspended in PBS to a final concentration 2*105/13 µl. The cell 886 
suspension was then mixed with 5 µl growth factor–reduced Matrigel and 2 µl Trypan blue solution 887 
and maintained on ice until injection. Aseptic conditions under a laminar flow hood were used 888 
throughout the surgical procedure. Female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (commonly known 889 
as the NOD SCID gamma; NSG) mice, 6–9 weeks old, were anesthetized with 375 mg/Kg Avertin, 890 
laid on their backs, and injected with a 20-µl cell suspension directly in the fourth mammary fad pad. 891 
After 4 weeks mice were sacrificed and the primary tumors were removed, cut by a scalpel and each 892 
tumor slide was placed over a metal grid inserted in 6-well plate to allow tumors to grow on an 893 
interface air/culture medium. Before imaging, 2.5µg/ml Doxycycline Hyclate was added to tumor 894 
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slices culture media to induce RAB5A expression. Tumor cells were maintained under stimulation 895 
for 3 days, changing the medium every day. 896 
 897 
Immunofluorescence  898 
As previously shown56, cells were fixed in 4% paraformaldehyde (PFA) and permeabilized with 0.1% 899 
Triton X-100 and 1% BSA 10 minutes (except for EEA-1 staining, permeabilized with 0.02% 900 
Saponin and 1% BSA 10 minutes and pERK1/2 staining, permeabilized with ice cold 100% Methanol 901 
for 10 minutes). In EGFR staining experiments, permeabilization step was avoided where indicated 902 
(non-permeabilized conditions) in order to detect only total cell surface EGFR. After 1X PBS wash, 903 
primary antibodies were added for 1 hour at room temperature. Coverslips were washed in 1X PBS 904 
before secondary antibody incubation 1 hour at room temperature, protected from light. FITC- or 905 
TRITC-phalloidin was added in the secondary antibody step, where applicable. After removal of not 906 
specifically bound antibodies by 1X PBS washing, nuclei were stained with 0.5 ng/ml DAPI. Samples 907 
were post-fixed and mounted on glass slides in anti-fade mounting medium (Mowiol). Antibodies 908 
were diluted in 1X PBS and 1% BSA. Images were acquired by wide-field fluorescence microscope 909 
or confocal microscope, as indicated in figure legends.  910 
Immunofluorescence on MCF10A-derived acini was performed by fixing acini with 4% 911 
paraformaldehyde for 20 minutes at RT. Then cells were permeabilized with 0.5% TRITON X-100 912 
in PBS for 10 minutes at 4oC and incubated with blocking solution (PBS + 0.1% BSA + 10% goat 913 
serum) for 1 hour at RT. Acini were incubated with indicated primary antibodies diluted in blocking 914 
solution for o/n at 4oC. The day after acini were incubated with indicated secondary antibodies diluted 915 
in blocking solution for 1 hour at RT. Finally, acini were incubated with DAPI in PBS for 20 minutes 916 
at RT. Samples were then maintained at 4oC in PBS before imaging. 917 
E-cadherin staining was analysed by confocal microscopy and images were processed to obtain the 918 
straightness index of the junction. “Junction length” was measured by tracking a straight line and 919 
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“junction tracking” was obtained by tracking manually the same junction following its profile. The 920 
straightness index of the junction has been quantified as the ratio of the junction length and the 921 
junction tracking.  922 
 923 
125I-EGF internalization assay  924 
Internalization of 125I-EGF was performed at low EGF (1 ng/ml) or high EGF (30 ng/ml) as described 925 
in ref.59. 926 
Briefly, MCF10A cells were plated in 24-well plates in at least duplicate for each time point, plus 927 
one well to assess non-specific binding. Cell monolayers were EGF-starved 24 hours and induced 928 
overnight by Doxycycline Hyclate. The day after cells were incubated in assay medium (DMEM/F12 929 
supplemented with Cholera Toxin (100 ng/ml), 0,1% BSA, 20mM Hepes, DOX (2.5µg/ml) and then 930 
incubated at 37°C in the presence of 1 ng/ml 125I-EGF, or 30 ng/ml EGF (1 ng/ml 125I-EGF (Perkin 931 
Elmer) + 29 ng/ml cold EGF. At different time points (2, 4, 6 min) the amount of bound 125I-EGF 932 
was measured with an acid wash solution pH 2.5 (0.2 M acetic acid, 0.5 M NaCl). Cells were then 933 
lysed with 1N NaOH, which represents the amount of internalized 125I-EGF. Non-specific binding 934 
was measured at each time point in the presence of an excess of non-radioactive EGF (300 times). 935 
After being corrected for non-specific binding, the rate of internalisation was calculated as the ratio 936 
between internalised and surface-bound radioactivity. Surface EGFRs were measured by 125I-EGF 937 
saturation binding as described60.  938 
 939 
EGF recycling assay 940 
Recycling assays of 125I-EGF were performed as described in60. In brief, cell monolayers were EGF-941 
starved 24 hours and induced overnight by Doxycycline Hyclate. The day after cells were incubated 942 
in assay medium (DMEM/F12 supplemented with Cholera Toxin (100ng/ml) , 0,1% BSA, 20mM 943 
Hepes, DOX (2.5µg/ml), then incubated with 125I-EGF (30 ng/ml: 5 ng/ml of 125I-EGF + 25 ng/ml of 944 
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cold EGF) for 15 min at 37 °C, followed by mild acid/salt treatment (buffer at pH 4.5, 0.2 M Na 945 
acetate pH 4.5, 0.5 M NaCl) to remove bound EGF. Cells were then chased at 37°C in a medium 946 
containing 4 µg/ml EGF for the indicated times, to allow internalization and recycling. At the end of 947 
each chase time, the medium was collected, half was counted directly (free) and half was subjected 948 
to TCA precipitation to determine the amount of intact/recycled (TCA precipitable) and degraded 949 
(TCA soluble) 125I-EGF present in it. Surface-bound 125I-EGF was extracted by acid treatment (0.5M 950 
NaCl, 0.2M acid acetic). Finally, cells were lysed in 1N NaOH to determine intracellular 125I-EGF. 951 
Data are expressed as the fraction of intact 125I-EGF in the medium with respect to the total (total 952 
medium + total surface + total intracellular). Non-specific counts were measured for each time point 953 
in the presence of a 300-fold excess of cold ligand, and were never >3-10 % of the total counts. 954 
 955 
Image acquisition 956 
Time-lapse imaging of 3D acini/spheroids motility was performed on a Leica TCS SP8 laser confocal 957 
scanner mounted on a Leica DMi8 microscope equipped with motorized stage; a HC PL FLUOTAR 958 
20X/0.5NA dry objective was used. A white light laser was used as illumination source. Leica 959 
Application Suite X (LAS X, https://www.leica-microsystems.com/products/microscope-960 
software/details/product/leica-las-x-ls/) was the software used for all the acquisitions. 961 
Image acquisition conditions were set to remove channel crosstalk, optimizing spectral detection 962 
bands and scanning modalities. ImageJ software was used for data analysis. 963 
Collagen SHG analysis on collagen embedded MCF10DCIS spheroids was performed with a 964 
confocal microscope (Leica; TCS SP5) on an upright microscope (DM6000 CFS) equipped with blue 965 
(argon, 488 nm), yellow (561 nm solid state laser), and red (633 nm solid state laser) excitation laser 966 
lines with an HCX PL APO 40X/1.25-0.75NA oil immersion objective and controlled by Leica LAS 967 
AF Lite software (Leica). We used a two-photon excitation (2PE) technique with a pulsed infrared 968 
laser (Chameleon Ultra II; Coherent) at 980 nm. 969 
 47 
EKAREV FRET analysis was performed using a DeltaVision Elite imaging system (Applied 970 
Precision) controlled by softWoRx Explorer 2.0 (Applied Precision) equipped with a DV Elite CMOS 971 
camera and an inverted microscope (IX71; Olympus) using a PlanApo N 60X/1.42NA oil-immersion 972 
objective lens. 973 
Ex vivo DCIS tumor slice motility assay was performed using an Olympus IX83 inverted microscope 974 
controlled by The Olympus cellSens Standard software (Olympus, https://www.olympus-975 
lifescience.com/en/software/cellsens/) and equipped with an iXon Ultra Andor (EMCCD) 16 bit 976 
camera using a UplanSApo 10X/0.4NA dry objective. 977 
 978 
AFM measurements of collagen gel 979 
Collagen gel samples at different concentration (2, 4, 6 mg/ml) were prepared as previously described 980 
in wells obtained by binding a microfabricated PDMS ring (height=2 mm, outer diameter=10 mm, 981 
inner diameter= 6 mm) to 24 mm-round glass coverslip via plasma treatment of the surfaces.  982 
The stiffness of collagen gel samples was measured at 37°C by using NanoWizard3 AFM (JPK, 983 
Germany) coupled to an Olympus inverted microscope. A silicon nitride AFM probe (nominal spring 984 
constant of 0.03 N/m: NovaScan, USA) functionalized with a borosilicate microsphere (10 µm in 985 
diameter) was used for AFM indentation. Prior to the measurements, the deflection sensitivity and 986 
spring constant of the cantilever were calibrated in PBS on glass at 37°C. 987 
Collagen gel stiffness was measured by bringing the bead-functionalized cantilever tip into contact 988 
with the matrix surface at 30 (or more) different positions. For each position five force curves were 989 
recorded. The contact force was set at a threshold value of 2 nN, the approach–retraction distance 990 
was 10 µm, and the approach velocity was 10 µm/s. 991 
The data points below 0.8 µm indentation depth were used to calculate the elastic (Young’s) modulus, 992 
by fitting the curves with the Hertz model: 993 
  F = 	 fg	 h(ijkl) 	5Rd	g	       (1) 994 
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where F is the indentation force, E is the Young’s modulus to be determined, ν is the Poisson’s ratio, 995 
R is the radius of the spherical bead, and δ is the indentation depth.  996 
 997 
Electron Microscopy 998 
Electron microscopic examination was performed as previously described61, 62. A description of each 999 
process is described below. 1000 
Embedding: the tissue and 3D spheroids were fixed with of 4% paraformaldehyde 1001 
and 2.5% glutaraldehyde (EMS, USA) mixture in 0.2 M sodium cacodylate pH 7.2 for 2 hours at 1002 
RT, followed by 6 washes in 0.2 sodium cacodylate pH 7.2 at RT. Then cells were incubated in 1:1 1003 
mixture of 2% osmium tetraoxide and 3% potassium ferrocyanide for 1 hour at RT followed by 6 1004 
times rinsing in 0.2 M cacodylate buffer. Then the samples were sequentially treated with 0.3% 1005 
thiocarbohydrazide in 0.2 M cacodylate buffer for 10 min and 1% OsO4 in 0.2 M cacodylate buffer 1006 
(pH 6,9) for 30 min. Then, samples were rinsed with 0.1 M sodium cacodylate (pH 6.9) buffer until 1007 
all traces of the yellow osmium fixative have been removed, washed in de-ionized water, treated 1008 
with 1% uranyl acetate in water for 1 h and washed in water again (Mironov et al., 2004; 1009 
Beznoussenko et al., 2015). The samples were subsequently subjected to de-hydration in ethanol 1010 
and then in acetone and embedded in Epoxy resin at RT and polymerized for at least 72 h in a 60 °C 1011 
oven. Embedded samples were then sectioned with diamond knife (Diatome, Switzerland) using 1012 
Leica ultramicrotome (Leica EM UC7; Leica Microsystems, Vienna). Sections were analyzed with 1013 
a Tecnai 20 High Voltage EM (FEI, Thermo Fisher Scientific, Eindhoven, The Netherlands) 1014 
operating at 200 kV62. 1015 
 1016 
Measurement of the cellular velocities and trajectories on monolayers  1017 
Coarse-grained maps of the instantaneous cellular velocities were obtained by analysing time-lapse 1018 
phase-contrast movies with a custom PIV software written in MATLAB56. The time interval between 1019 
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consecutive frames was 5 min or 10 min. The interrogation window was 32X32 pixels (pixel size 1020 
1.29 µm or 1.6 µm), with an overlap of 50% between adjacent windows. The number of cells 1021 
comprised within one field-of-view (FOV) was typically 2500. For a given monolayer, time-lapse 1022 
images from different (typically from 5 to 10) FOVs were simultaneously collected.  1023 
The instantaneous root mean square velocity 𝑣#$%(𝑡)  of a cell monolayer was computed 1024 
as	𝑣#$%(𝑡) = 5〈|𝒗(𝑡)|n〉𝒙,q, where 𝒗(𝑡) is the instantaneous velocity vector and 〈⋅〉𝒙,q indicates an 1025 
average over all grid points 𝒙 (corresponding to the centers of the PIV interrogation windows) and 1026 
FOVs 𝑗, respectively. 1027 
The instantaneous order parameter 𝜓(𝑡) of a cell monolayer was computed as 𝜓(𝑡) = 〈|〈𝒗(t)〉𝒙|l〈|𝒗(t)|l〉𝒙〉q. 1028 
This definition is such that 0 ≤ 𝜓(𝑡) ≤ 1. In particular, 𝜓(𝑡) = 1 only if, within each FOV, the 1029 
velocity field is perfectly uniform, i.e. all the cells in the monolayer move with the same speed and 1030 
in the same direction. On the contrary 𝜓(𝑡) ≅ 0 is expected for a randomly oriented velocity field. 1031 
The vectorial velocity correlation functions were calculated as 𝐶<<(𝑟) = 〈|〈𝒗(𝒙w𝒓,t)⋅𝒗(𝒙,t)〉𝒙,y|l〈|𝒗|l〉𝒙,y 〉q . 1032 
Unless otherwise stated in the main text, the temporal average 〈⋅〉t  was always performed over the 1033 
time window comprised between 4 and 12 hours from the beginning of the image acquisition. 1034 
The velocity correlation function 𝐿JKLL  is obtained by fitting 𝐶<<(𝑟) with a stretched exponential 1035 
function of the form	𝑓(𝑟) = (1 − 𝛼)𝑒j(L }~⁄ ) + 𝛼. Here 𝛾 is a stretching exponent and 𝛼 is an 1036 
offset which is non-zero in presence of a collective migration of the monolayer. 1037 
Cellular trajectories 𝒓(𝑡) were calculated by numerical integration of the instantaneous velocity 1038 
field as obtained from the PIV analysis (see ref.63 and reference therein). For each FOV a number of 1039 
trajectories roughly corresponding to the number of cells was computed.  1040 
Mean squared displacements (MSDs) of the cells were calculated as	𝑀𝑆𝐷(∆𝑡) = 〈|𝒓(𝑡 + ∆𝑡) −1041 𝒓(𝑡)|n〉, where the average was performed over all the trajectories and, unless otherwise stated in 1042 
the main text, in the time window comprised between 4 and 12 hours after the beginning of the 1043 
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experiment. In order to estimate the persistence length 𝐿MNLO of the cellular motion the MSD curves 1044 
were fitted with a function of the form	𝑔(𝛥𝑡) = (𝑢D𝛥𝑡)n1 + 𝑢D𝛥𝑡/𝐿MNLOji . This expression 1045 
describes a transition between a short-time ballistic-like scaling and a long-time diffusive scaling. 1046 
The transition between the two regimes takes place for 𝛥𝑡 ≈ 1/𝑢D𝐿MNLO, i.e. after the cell has travelled 1047 
with an approximately constant velocity over a distance ≈ 𝐿MNLO. 1048 
 1049 
Measurement of the cellular velocities of acini 1050 
Sequences of confocal Z stacks of 3D acini were analysed with an adapted PIV scheme in order to 1051 
extract a representative value for the migration velocity, to assess the collective nature of the cellular 1052 
motion and to detect the presence of a coherent rotational motion. Details about the imaging are given 1053 
in the paragraph “Image acquisition”. 1054 
The geometrical centre 𝒙J of each acinus was determined as the centroid of the corresponding 3D 1055 
fluorescent intensity distribution (Z stack) 𝐼(𝒙|𝑡): 𝒙J = ∑ (𝒙|t)𝒙∑ (𝒙,t)  , where the sum is performed over all 1056 
voxels and time points. For each time point, the 3D fluorescent intensity distribution was radially 1057 
projected onto the unit sphere centred in 𝒙J leading to a sequence of 2D intensity maps 𝑖(𝜃, 𝜑|𝑡),  1058 
where 𝜃 and 𝜑 are the polar and the azimuthal angle spanning the sphere, respectively. In practice, 1059 𝑖(𝜃, 𝜑|𝑡) was obtained from a representation of 𝐼(𝒙|𝑡) in spherical coordinates, after summation over 1060 
the radial coordinate. For each time point, 𝑖  is represented by a 512x128 matrix, each element 1061 
covering the Cartesian product of angular intervals of constant amplitudes △ 𝜃 = 𝜋/512 and △ 𝜑 =1062 2𝜋/128, respectively.  1063 
We performed on 𝑖 a 2D PIV analysis as described in the previous paragraph, by treating (𝜃, 𝜑) as 1064 
Cartesian coordinates. The obtained coarse-grained velocity fields [𝑢(𝜃, 𝜑|𝑡), 𝑢(𝜃, 𝜑|𝑡)] (in units 1065 
of  rad/hr) were then used to reconstruct the tangential velocity  field 𝒗(𝜃, 𝜑) = 𝑅D	𝑢(𝜃, 𝜑|𝑡)𝒏 +1066 
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	𝑢(𝜃, 𝜑|𝑡) sin 𝜃 𝒏 of the acinus. Here, 𝒏  and 𝒏  are the polar and the azimuthal unit vector, 1067 
respectively and 𝑅D=∑(𝒙|t)(𝒙j𝒙𝒄)𝟐∑ (𝒙,t)  is the radius of gyration of the acinus. 1068 
The root mean squared velocity was calculated as	𝑣#$%(𝑡) = 5〈|𝒗|𝟐〉, where the angular brackets 1069 
indicate an average performed over the whole sphere. The presence of a pattern of global rotation 1070 
was monitored by measuring the total angular momentum 𝒍 = 〈𝒓 × 𝒗〉, where 𝒓  is a unit vector 1071 
spanning the whole sphere. The direction of 𝒍 identifies the orientation of the axis of instantaneous 1072 
rotation. The collective nature of the cellular motility is captured by the non-dimensional rotational 1073 
order parameter 𝜓 = ¡n |𝒍|lk¢£¤l . The normalization of the order parameter is such that, for a rigidly 1074 
rotating sphere, 𝜓 = 1, while, in the absence of coordinated motion one expects 𝜓 ≅ 0. 1075 
Phase contrast Rotation analysis of acini: Maps of the instantaneous cellular velocities were obtained 1076 
by analysing time-lapse movies and performing a PIV (Particle Image Velocimetry) analysis using 1077 
the Matlab MPIV toolbox (http://www.oceanwave.jp/softwares/mpiv/ and 1078 
https://www.mathworks.com/help/matlab/ref/curl.html) with the MQD (Minimum Quadric 1079 
Differences) algorithm and an interrogation window of 24 pixels X 24 pixels with an overlap of 50%. 1080 
From the maps of the instantaneous cellular velocities for each frame, we computed the map of curl 1081 
of the velocity field using the Matlab function curl. For each frame, we evaluated the rotation of the 1082 
acini as the average of absolute value of the curl map. 1083 
 1084 
Kinematic and dynamical analysis of spheroids 1085 
Overall motility and internal dynamics of control and RAB5A-MCF10A-expressing mCherry-H2B 1086 
spheroids were measured by analysing time sequences of confocal Z stacks, according to the 1087 
following procedure, implemented in a custom MATLAB® code. More details about the imaging 1088 
can be found in the paragraph “Image acquisition”. 1089 
 52 
We indicate with 𝑅(𝚯, 𝑼) the roto-translational operator given by the composition of a 3D rotation 1090 
by an angle |𝚯| around the axis identified by the direction of the 3D vector 𝚯 and a translation of 1091 
vector 𝑼. 𝑅(𝚯,𝑼) is a linear operator and its numerical implementation as a transformation between 1092 
3D matrices (Z stacks) was realized via the MATLAB functions imwrap and affine3d. 1093 
Let us consider two 3D stacks 𝐼(𝒙, 𝑡)	 and  𝐼(𝒙, 𝑡 + Δ𝑡D), where Δ𝑡D is delay between consecutive 1094 
stacks. We define 𝛀(𝑡)  and 𝑼(𝑡)  as the 3D vectors that minimize the distance 𝑑  (namely, the 1095 
variance of the difference) between 𝐼(𝒙, 𝑡 + Δ𝑡D) and 𝑅(𝛚Δ𝑡D, 𝒖)𝐼(𝒙, 𝑡) :  𝑑(𝛚, 𝒖|𝑡) = ‖𝐼(𝒙, 𝑡 +1096 Δ𝑡D) − 𝑅(𝛚Δ𝑡D, 𝒖)𝐼(𝒙, 𝑡)‖n . Numerically, the minimization is performed by exploiting the 1097 
MATLAB function imregtform. In substance,	.  1098 
The residual internal restructuring dynamics is measured via a general	𝑅𝜴(𝑡)𝛥𝑡D, 𝑼(𝑡) is the rigid 1099 
transformation that reproduces at best the changes occurred in 𝐼(𝒙, 𝑡) during the time interval Δ𝑡D. 1100 
According to the definitions above,	𝜴(𝑡) provides the best estimate for the instantaneous vectorial 1101 
angular velocity of the spheroid, the direction of 𝒏(𝑡) = 𝜴(t)|𝜴(t)| identifying the axis of instantaneous 1102 
rotation. The temporal persistence of the rotational motion is captured by the orientational correlation 1103 
function 𝐶𝒏(𝛥𝑡) = 〈𝒏(𝑡 + Δt) ⋅ 𝒏(𝑡)〉t , where Δ𝑡 = 𝑛Δ𝑡D . In order to estimate the rotational 1104 
correlation time 𝜏° , 𝐶𝒏(𝛥𝑡)  was fitted with an exponential function of the form 	𝑓(𝛥𝑡) =1105 exp(−Δ𝑡/𝜏°)ization to the 3D case of a recently introduced method (Difference Variance Analysis, 1106 
DVA) for the quantification of the dynamics of particulate soft matter systems64. The non-rigid part 1107 
of the changes occurring within a spheroid between time 𝑡 and 𝑡 + Δ𝑡, where Δ𝑡 = 𝑛Δ𝑡D, is captured 1108 
by the parameter: 𝑞(Δ𝑡, 𝑡) = 1 − 𝛽ji‖𝐼(𝒙, 𝑡 + Δ𝑡) − 𝑇(Δ𝑡, 𝑡)𝐼(𝒙, 𝑡)‖n , where𝑇(Δ𝑡, 𝑡) = 𝑅(𝛀(𝑡 +1109 𝑛𝛥𝑡D)𝛥𝑡,𝑼(𝑡 + 𝑛𝛥𝑡D)) ∘ 𝑅(𝛀(𝑡 + (𝑛 − 1)𝛥𝑡D)𝛥𝑡,𝑼(𝑡 + (𝑛 − 1)𝛥𝑡D)) ∘ …	∘ 𝑅(𝛀(t)Δ𝑡, 𝑼(𝑡))  is 1110 
the composition of elementary roto-translations and 𝛽 = 2〈𝐼n〉t,𝒙 − 〈𝐼〉t,𝒙n. The definition of 𝑞 is 1111 
such that, neglecting noise and truncation errors,  𝑞 ≅ 1 if the spheroids is immobile or if it undergoes 1112 
a perfectly rigid displacement and/or rotation, with no relative motion between different cells. On the 1113 
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contrary, one gets 𝑞 ≅ 0 when almost all the cells have performed positional rearrangements on a 1114 
length scale comparable with their size, leading to a substantial change in the local structure64. We 1115 
consider the so-called overlap parameter 𝑄 , obtained as a temporal average of 𝑞 : 𝑄(Δ𝑡) =1116 〈𝑞(Δ𝑡, 𝑡)〉t.   1117 
By fitting the decay of 𝑄 with an exponential function 𝑄(Δ𝑡) = 𝑄D𝑒j·t/¸ , we can extract an estimate 1118 
of the characteristic correlation time 𝜏  after which an almost complete change in the cellular 1119 
configuration has occurred. 1120 
Moreover, in order to spot potential spatial inhomogeneities in the dynamics, in particular a 1121 
dependence of the relaxation time on the radial coordinate 𝑟 = |𝒙| (in a reference frame where 𝒙 = 0 1122 
corresponds to the center of the spheroid), we also considered a space-resolved version	𝑄O(Δ𝑡, 𝑟) =1123 〈𝑞O(Δ𝑡, 𝑡, 𝒙)〉t,|𝒙|¹L of the above-defined overlap parameter, where 𝑞O(Δ𝑡, 𝑡, 𝒙) = 1 − 𝛽Oji[𝐼(𝒙, 𝑡 +1124 Δ𝑡) − 𝑇(Δ𝑡, 𝑡)𝐼(𝒙, 𝑡)]n and 𝛽O = 2〈𝐼n〉t,|𝒙|¹L − 〈𝐼〉t,|𝒙|¹Ln. According to the above definitions, the 1125 
decay of 𝑄O(Δ𝑡, 𝑟) captures the relaxation dynamics at different distances 𝑟 from the center of the 1126 
spheroid. Instead of performing a fit, we extracted the relaxation rate Γ(𝑟) = 1 𝜏(𝑟)⁄  associated with 1127 
the decay of 𝑄O(Δ𝑡, 𝑟) as a function the delay time Δ𝑡 in a simple and robust manner by considering 1128 
the difference quotient at the origin of the temporal axis: Γ(𝑟) ≅ −[𝑄O(Δ𝑡D, 𝑟) − 𝑄O(0, 𝑟)]/Δ𝑡D. 1129 
 1130 
Reference-free estimation of the fluctuating Root Mean Square stresses: Stress Fluctuation 1131 
Microscopy 1132 
Spatial maps of the Root Mean Square (RMS) stresses in the ECM surrounding MCF10.DCIS.com 1133 
spheroids were obtained by analyzing the positional fluctuations of embedded, fluorescent tracer 1134 
particles by using Stress Fluctuation Microscopy, as described below. The procedure was applied to 1135 
4D stacks (𝑥𝑦𝑧𝑡) obtained from time-lapse confocal acquisitions. Each stack included 72 time points 1136 
and 35 Z planes, each plane having a resolution of 512x512 pixels. Delay between frames was 20 1137 
minutes, voxel size was (𝑥𝑦𝑧) 0.57x0.57x3.00 𝜇𝑚g. 1138 
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The instantaneous velocity field 𝒗(𝒙, 𝑡) = 𝜕t𝒖(𝒙, 𝑡) associated with the motion of the fluorescent 1139 
tracers embedded in the ECM was obtained via a custom Lucas-Kanade optical flow algorithm 65 1140 
implemented in MATLAB (Gaussian weighted window (𝜎  = 2 pixels), mesh size: 10 pixels) 1141 
(Supplementary Figure 10A-B and Supplementary Movie 27). Here, 𝒖(𝒙, 𝑡)  represents the 1142 
displacement field of the ECM with respect to its (unknown) mechanical equilibrium condition. We 1143 
note that the time derivative of the strain tensor 𝜀Áq(𝒙, 𝑡) ≡ 𝜕Á𝑢q(𝒙, 𝑡) can be written in terms of a 1144 
spatial derivative of the velocity as 𝜕t𝜀Áq(𝒙, 𝑡) = 𝜕Á𝑣q(𝒙, 𝑡). This last equality enables estimating the 1145 
mean squared value (MSV) of the strain fluctuation ∆𝜀Áq(𝜏) ≡ 𝜀Áq(𝑡D + 𝜏) − 𝜀Áq(𝑡D) as an integral of 1146 
the temporal correlation function 𝐶Áq(𝑡) ≡ 〈𝜕Á𝑣q(𝑡 + 𝑡D)𝜕Á𝑣q(𝑡D)〉	66 1147 〈∆𝜀Áq(𝜏)n〉 = 2∫ (𝜏 − |𝑡|)D¸ 𝐶Áq(𝑡)𝑑𝑡,     (2) 1148 
where the dependence on the spatial coordinate 𝒙 has been omitted for clarity. Temporal correlation 1149 
functions 𝐶Áq(𝑡)  evaluated in proximity of the boundary of different spheroids are shown in 1150 
Supplementary Fig. 10C. We found that 〈∆𝜀Áq(𝜏)n〉 rapidly saturates to a 𝜏-independent asymptotic 1151 
value 〈∆𝜀Áqn〉.  Once obtained the MSV 〈∆𝜀Áqn〉	of the strain fluctuation, the MSV 〈∆𝜎Áqn〉	of the stress 1152 
fluctuation can be obtained via the constitutive equations of the material, which we assumed to be 1153 
isotropic and homogeneous. This assumption relies on the fact that the length scales probed in our 1154 
experiments (a few microns) are about one order of magnitude larger than the characteristic mesh 1155 
size on the collagen network 67. Moreover, we adopt the approximation of negligible compressibility 1156 
(i.e. that the Poisson ratio of the material is 0.5) 68. Under these hypotheses, the mechanical response 1157 
of the material is described in terms of a single parameter, namely the Young modulus 𝐸, that we 1158 
measured directly with AFM indentation experiments.   1159 
In this work, the above-described procedure has been applied on the equatorial plane of each spheroid, 1160 
by considering the 2D intensity distribution obtained as a 𝑧-average of 3 adjacent confocal planes. 1161 
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Therefore, only the in-plane components of the velocity, strain and stress were considered.  In this 1162 
simplified geometry, the diagonal components of the fluctuating stress tensor are given by 1163 〈∆𝜎iin〉 = Ä ÅijÆlÇn 〈∆𝜀iin〉 + 𝜈n〈∆𝜀nnn〉     (3) 1164 〈∆𝜎nnn〉 = Ä ÅijÆlÇn 〈∆𝜀nnn〉 + 𝜈n〈∆𝜀iin〉     (4) 1165 
while the mean value of the normal stress can be calculated as 1166 〈∆𝜎n〉 = 𝐸n iwÆl(ijÆl)l 〈∆𝜀n〉       (5) 1167 
where 〈∆𝜀n〉 = (〈∆𝜀iin〉 + 〈∆𝜀nnn〉)/2. The level of uncertainty associated with this analysis was 1168 
estimated by applying the described procedure to n=5 confocal stacks collected with the same 1169 
acquisition parameters in portions of the fluorescent particles-seeded collagen gel far from the 1170 
embedded spheroids. The obtained MSV of the “background” normal stress was	〈∆𝜎n〉|ÉÊË = 50 ±1171 3	𝑃𝑎n , about one order of magnitude smaller of the peak values obtained in the presence of a spheroid 1172 
(see Supplementary Figure 10D). We estimated the Root Mean Square (RMS) value 𝜎#$%	of the 1173 
fluctuating stress in the presence of the spheroids by subtracting this spurious contribution from the 1174 
measured MSV: 	𝜎#$% = 5〈∆𝜎n〉 −	〈∆𝜎n〉|ÉÊË . We note that, in principle, the above-described 1175 
formalism could be easily adapted to reconstruct the full 3D distribution of the fluctuating stresses. 1176 
Nevertheless, the limited axial resolution of the confocal acquisition system imposes a substantial 1177 
limitation on the accuracy of the reconstructed tracer’s displacements along 𝑧, with an obvious impact 1178 
on the reconstructed stresses. The solution of this problem is beyond the scope of this work and will 1179 
be investigated in future publication. 1180 
 1181 
Statistical analysis 1182 
Student's unpaired and paired t-test was used for determining the statistical significance whenever we 1183 
compared in a pairwise fashion two distinct distribution. In the case of the endosome size distribution 1184 
comparing multiple treatments (Control, RAB5A, RAB5B and RAB5C) Chi-sqaure or Mann-1185 
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Whitney or Tuckey tests were applied as indicated. In Figure 8C, P-values of the Kaplan Mayer 1186 
curves are were calculated using a log-rank test. Significance was defined as ∗p < 0.05; ∗∗p < 0.01; 1187 ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001. Statistic calculations were performed with GraphPad Prism 8 1188 
Software (https://www.graphpad.com/scientific-software/prism/). Data are expressed as mean ± SD, 1189 
unless otherwise indicated. 1190 
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